Global AI-Based Digital Pathology Solutions Market, by Type of Neural Network, (Value US$ Mn)
Global AI-Based Digital Pathology Solutions Market, by Type Of Assay, (Value US$ Mn)
Global AI-Based Digital Pathology Solutions Market, by Type Of Target Disease Indication, (Value US$ Mn)
Global AI-Based Digital Pathology Solutions Market, by Application, (Value US$ Mn)
Global AI-Based Digital Pathology Solutions Market, by End-User, (Value US$ Mn)
Global AI-Based Digital Pathology Solutions Market, by Region, (Value US$ Mn)
North America AI-Based Digital Pathology Solutions Market, by Country, (Value US$ Mn)
Europe AI-Based Digital Pathology Solutions Market, by Country, (Value US$ Mn)
Asia Pacific AI-Based Digital Pathology Solutions Market, by Country, (Value US$ Mn)
Latin America AI-Based Digital Pathology Solutions Market, by Country, (Value US$ Mn)
Middle East & Africa AI-Based Digital Pathology Solutions Market, by Country, (Value US$ Mn)
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Artificial Intelligence (AI)-based Digital Pathology Market Snapshot
Chapter 4. Global Artificial Intelligence (AI)-based Digital Pathology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Neural Network, Estimates & Trend Analysis
5.1. By Neural Network, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Neural Network:
5.2.1. Artificial Neural Network
5.2.2. Convolutional Neural Network
5.2.3. Fully Convolutional Network
5.2.4. Recurrent Neural Network
5.2.5. Other Neural Networks
Chapter 6. Market Segmentation 2: By Assay Estimates & Trend Analysis
6.1. By Assay & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Assay:
6.2.1. ER Assay
6.2.2. HER2 Assay
6.2.3. Ki67 Assay
6.2.4. PD-L1 Assay
6.2.5. PR Assay
6.2.6. Other Assays
Chapter 7. Market Segmentation 3: By Applications Estimates & Trend Analysis
7.1. By Applications & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Applications:
7.2.1. Diagnostics
7.2.2. Research
7.2.3. Other Areas of Application
Chapter 8. Market Segmentation 4: By End-Users Estimates & Trend Analysis
8.1. By End-Users & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-Users:
8.2.1. Academic Institutions
8.2.2. Hospitals/Healthcare Institutions
8.2.3. Laboratories/Diagnostic Institutions
8.2.4. Research Institutes
8.2.5. Other End-Users
Chapter 9. Market Segmentation 5: By Target Disease Indication Estimates & Trend Analysis
9.1. By Target Disease Indication & Market Share, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Target Disease Indication:
9.2.1. Breast Cancer
9.2.2. Colorectal Cancer
9.2.3. Cervical Cancer
9.2.4. Gastrointestinal Cancer
9.2.5. Lung Cancer
9.2.6. Prostate Cancer
9.2.7. Other Indications
Chapter 10. Artificial Intelligence (AI)-based Digital Pathology Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts By Neural Network, 2021-2034
10.1.2. North America Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts By Assay, 2021-2034
10.1.3. North America Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034
10.1.4. North America Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034
10.1.5. North America Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts by Target Disease Indication, 2021-2034
10.1.6. North America Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) By Neural Network, 2021-2034
10.2.2. Europe Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) By Assay, 2021-2034
10.2.3. Europe Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) By Applications, 2021-2034
10.2.4. Europe Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034
10.2.5. Europe Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts by Target Disease Indication, 2021-2030
10.2.6. Europe Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) By Neural Network, 2021-2034
10.3.2. Asia Pacific Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) By Assay, 2021-2034
10.3.3. Asia Pacific Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) By Applications, 2021-2034
10.3.4. Asia Pacific Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034
10.3.5. Asia Pacific Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts by Target Disease Indication, 2021-2034
10.3.6. Asia Pacific Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) By Neural Network, (US$ Million) 2021-2034
10.4.2. Latin America Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) By Assay, (US$ Million) 2021-2034
10.4.3. Latin America Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) By Applications, (US$ Million) 2021-2034
10.4.4. Latin America Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034
10.4.5. Latin America Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts by Target Disease Indication, 2021-2034
10.4.6. Latin America Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) By Neural Network, (US$ Million) 2021-2034
10.5.2. Middle East & Africa Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) By Assay, (US$ Million) 2021-2034
10.5.3. Middle East & Africa Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) By Applications, (US$ Million) 2021-2034
10.5.4. Middle East & Africa Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2030
10.5.5. Middle East & Africa Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) estimates and forecasts by Target Disease Indication, 2021-2030
10.5.6. Middle East & Africa Artificial Intelligence (AI)-based Digital Pathology Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. PathAI
11.2.2. Paige.AI
11.2.3. Akoya Biosciences
11.2.4. Aiforia
11.2.5. aetherAI
11.2.6. CellCarta
11.2.7. Deep Bio Inc.
11.2.8. DoMore Diagnostics
11.2.9. PROSCIA
11.2.10. Pramana, Inc.
11.2.11. Visiopharm A/S
11.2.12. Roche Tissue Diagnostics
11.2.13. Indica Labs
11.2.14. Ibex Medical Analytics
11.2.15. LDPath
11.2.16. OracleBio Limited
11.2.17. Verily
11.2.18. Mindpeak GmbH
11.2.19. Proscia Inc.
11.2.20. SamanTree Medical SA
11.2.21. Tempus AI
11.2.22. Techcyte, Inc.
11.2.23. Tribun Health
11.2.24. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.